PIUR IMAGING

PIUR IMAGING

Vienna, Austria· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $12M

Overview

PIUR IMAGING is a private, commercial-stage company offering an AI software platform that transforms conventional 2D ultrasound devices into intelligent, automated 3D imaging systems. By providing a vendor-agnostic solution, PIUR enables healthcare providers to enhance diagnostic consistency, reduce operator dependency, and significantly accelerate scan-to-report times without capital-intensive hardware replacement. The company has established early commercial traction in Europe and the US, primarily in thyroid and vascular imaging, and is positioned to address widespread inefficiencies in global ultrasound workflows.

Endocrinology (Thyroid)Cardiovascular

Technology Platform

Vendor-agnostic AI software platform that upgrades existing 2D ultrasound systems to enable automated 3D volumetric imaging, AI-assisted annotation/measurement, and automated reporting.

Funding History

2
Total raised:$12M
Series A$10M
Seed$2M

Opportunities

The large installed base of ultrasound devices globally represents a vast, underserved market for AI-driven workflow optimization.
Growing shortages of skilled sonographers and pressure to increase diagnostic throughput create strong demand for automation tools that improve efficiency and consistency.

Risk Factors

Facing competition from both large incumbent ultrasound manufacturers integrating AI and other agile software startups.
Regulatory pathways for AI-based medical software are complex and vary by region, posing a hurdle to market expansion.

Competitive Landscape

Competitors include integrated AI suites from major ultrasound OEMs (e.g., GE HealthCare, Philips, Siemens Healthineers) and specialized AI software companies like Caption Health, Butterfly Network, and numerous startups. PIUR's key differentiation is its claimed vendor-agnostic compatibility, allowing it to target the entire legacy device market.